File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancer

TitleRandomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancer
Authors
Issue Date2014
Citation
Annals of Oncology, 2014, v. 25, p. 1578-1584 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/202738
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorMok, TSen_US
dc.contributor.authorGeater, SLen_US
dc.contributor.authorIannotti, Nen_US
dc.contributor.authorThongprasert, Sen_US
dc.contributor.authorSpira, Aen_US
dc.contributor.authorSmith, Den_US
dc.contributor.authorLee, VHFen_US
dc.contributor.authorLim, WTen_US
dc.contributor.authorReyderman, Len_US
dc.contributor.authorWang, Ben_US
dc.date.accessioned2014-09-19T09:33:32Z-
dc.date.available2014-09-19T09:33:32Z-
dc.date.issued2014en_US
dc.identifier.citationAnnals of Oncology, 2014, v. 25, p. 1578-1584en_US
dc.identifier.urihttp://hdl.handle.net/10722/202738-
dc.languageengen_US
dc.relation.ispartofAnnals of Oncologyen_US
dc.titleRandomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung canceren_US
dc.typeArticleen_US
dc.identifier.emailLee, VHF: vhflee@hku.hken_US
dc.identifier.authorityLee, VHF=rp00264en_US
dc.identifier.doi10.1093/annonc/mdu174en_US
dc.identifier.pmid24827127-
dc.identifier.hkuros237796en_US
dc.identifier.volume25en_US
dc.identifier.spage1578en_US
dc.identifier.epage1584en_US
dc.identifier.isiWOS:000340101600020-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats